Meriwether Wealth & Planning’s Charles River Laboratories CRL Stock Holding History

Meriwether Wealth & Planning’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.06K	Buy	+7	New	+$1.84K	﹤0.01%	647

Other funds holding CRL

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Lawson Kroeker Investment Management Omaha, Nebraska $360M AUM 21.88% 1-Year Est. Return

Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return

Sendero Wealth Management San Antonio, Texas $1B AUM 21.35% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

Meriwether Wealth & Planning's CRL Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Charles River Laboratories (CRL) in Q3 2026: 7 shares worth $2.06K. The stake represents ﹤0.01% of the portfolio and ranks #647 among its holdings.

111 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

Meriwether Wealth & Planning held 7 shares of Charles River Laboratories worth $2.06K as of Q3 2026.
Charles River Laboratories was a new Meriwether Wealth & Planning position in Q3 2026.
Charles River Laboratories made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #647 holding.
111 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.